Sustained efficacy of eptinezumab in participants with migraine for whom prior preventive treatments failed and who self-reported psychiatric comorbidities: Post hoc analysis of the placebo-controlled DELIVER trial

Article full text The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).